Bannayan-Riley-Ruvalcaba Syndrome (BRRS) (Symptoms,Causes and Treatment)

Bannayan-Riley-Ruvalcaba Syndrome (BRRS), also known as Bannayan-Zonana syndrome or BRRS1, is a rare genetic disorder characterized by a combination of features affecting various systems of the body. Here is some brief information about Bannayan-Riley-Ruvalcaba Syndrome:

1-Clinical Features: BRRS is typically diagnosed in childhood or early adolescence. The syndrome is characterized by a triad of clinical features, which may vary in their severity and presentation among affected individuals. These features include:

*Macrocephaly: Enlarged head size, often noticed in early childhood.

*Lipomas: Noncancerous fatty tumors that can occur under the skin or in other organs.

*Pigmented Macules: Darkly pigmented spots or freckles on the penis, vulva, or lips.

2-Additional Features: In addition to the triad, individuals with BRRS may exhibit other clinical features, which can include:

*Developmental Delay: Some individuals may experience delays in reaching developmental milestones, such as motor skills or language development.

*Intellectual Disability: Intellectual disability or learning difficulties may be present in some cases, ranging from mild to moderate.

*Muscle Hypotonia: Reduced muscle tone or muscle weakness may be observed.

*Vascular Anomalies: Certain vascular abnormalities, such as abnormal blood vessels or an increased risk of blood clots, can occur.

*Gastrointestinal Polyps: Polyps may develop in the gastrointestinal tract, particularly in the colon.

3-Association with PTEN Gene: BRRS is associated with mutations in the PTEN gene, which is involved in regulating cell growth and division. PTEN gene mutations can lead to the development of other related disorders, such as Cowden syndrome and PTEN hamartoma tumor syndrome (PHTS). These disorders share overlapping features with BRRS.

4-Genetic Inheritance: BRRS follows an autosomal dominant inheritance pattern, which means that an affected individual has a 50% chance of passing the condition on to each of their children.

5-Diagnosis and Management: BRRS is diagnosed based on clinical features, family history, and genetic testing to identify mutations in the PTEN gene. Management of BRRS involves regular medical surveillance and monitoring for associated conditions, such as thyroid abnormalities, gastrointestinal polyps, and certain cancers. Screening for developmental delays and intellectual disabilities may also be necessary. Treatment is focused on addressing specific symptoms and associated conditions as needed.

It’s important to note that BRRS is a complex and rare syndrome, and the clinical presentation can vary widely among individuals. Therefore, a comprehensive evaluation by a medical geneticist or other healthcare professionals experienced in genetic disorders is crucial for accurate diagnosis, appropriate management, and genetic counseling for affected individuals and their families.

This article covers the following topics :

What is Bannayan-Riley-Ruvalcaba syndrome?

Bannayan-Riley-Ruvalcaba Syndrome (BRRS), also known as Bannayan-Zonana syndrome or BRRS1, is a rare genetic disorder that primarily affects multiple systems of the body. It is named after the three physicians who first described the syndrome. BRRS is characterized by a combination of clinical features involving the skin, gastrointestinal tract, central nervous system, and other organs.

Here are some key characteristics and features of Bannayan-Riley-Ruvalcaba Syndrome:

1-Macrocephaly: Individuals with BRRS typically have an enlarged head size (macrocephaly) compared to their peers. This characteristic is often noticeable in early childhood.

2-Lipomas: Noncancerous fatty tumors called lipomas can develop under the skin or in other areas of the body. These lipomas are typically soft, painless, and slow-growing.

3-Pigmented Macules: Darkly pigmented spots or freckles, also known as pigmented macules, can be present on the penis, vulva, or lips. These spots are often seen during childhood and are considered a characteristic feature of BRRS.

4-Other Clinical Features: BRRS can also be associated with additional clinical features, which may vary among individuals. These can include:

*Vascular malformations or abnormalities, such as abnormal blood vessels or an increased risk of blood clots.

*Intellectual disability or learning difficulties, ranging from mild to moderate.

*Developmental delays in motor skills or language acquisition.

*Muscle hypotonia (low muscle tone) or weakness.

*Gastrointestinal polyps, particularly in the colon.

5-Genetic Cause: BRRS is caused by mutations in the PTEN gene, which plays a role in regulating cell growth and division. PTEN gene mutations are also associated with other related disorders, such as Cowden syndrome and PTEN hamartoma tumor syndrome (PHTS).

6-Inheritance Pattern: BRRS follows an autosomal dominant inheritance pattern. This means that an affected individual has a 50% chance of passing the condition on to each of their children.

Diagnosis of BRRS involves a combination of clinical evaluation, assessment of the characteristic features, and genetic testing to identify mutations in the PTEN gene. Management of BRRS typically involves regular medical surveillance and monitoring for associated conditions, as well as addressing specific symptoms and related health concerns.

It’s important to consult with a medical geneticist or other healthcare professionals experienced in genetic disorders for accurate diagnosis, appropriate management, and genetic counseling for individuals and families affected by Bannayan-Riley-Ruvalcaba Syndrome.

How common is BRRS?

Bannayan-Riley-Ruvalcaba Syndrome (BRRS) is considered a rare disorder. The exact prevalence of BRRS in the general population is not well-established. It is estimated to affect fewer than 1 in 200,000 individuals. However, due to underdiagnosis and variability in clinical presentation, the true prevalence may be higher than reported.

BRRS is a genetically inherited condition, and its occurrence is generally sporadic. It can affect individuals of any gender, race, or ethnicity. In some cases, BRRS can run in families, following an autosomal dominant inheritance pattern. This means that if an individual has BRRS, there is a 50% chance of passing the condition on to each of their children.

Since BRRS shares overlapping features with other conditions associated with PTEN gene mutations, such as Cowden syndrome and PTEN hamartoma tumor syndrome (PHTS), it can sometimes be challenging to differentiate between these disorders. The overall prevalence of all PTEN-related conditions combined is estimated to be around 1 in 200,000 to 1 in 250,000 individuals.

It’s important to note that the rarity of BRRS means that it may not be widely recognized or familiar to all healthcare professionals. Consequently, proper diagnosis and management may require consultation with specialists experienced in genetic disorders, such as medical geneticists or genetic counselors.

What are the symptoms of BRRS?

Bannayan-Riley-Ruvalcaba Syndrome (BRRS) is characterized by a range of symptoms that can vary in their severity and presentation among affected individuals. The symptoms may become apparent in infancy or early childhood. Here are the common symptoms and features associated with BRRS:

1-Macrocephaly: Macrocephaly refers to an enlarged head size. Children with BRRS typically have a larger head circumference compared to their peers.

2-Lipomas: Noncancerous fatty tumors called lipomas may develop under the skin or in other organs of individuals with BRRS. These lipomas are usually soft, painless, and slow-growing.

3-Pigmented Macules: Darkly pigmented spots or freckles, known as pigmented macules, can be seen on the penis, vulva, or lips of affected individuals. These macules are often present in childhood.

4-Developmental Delay: Some individuals with BRRS may experience delays in reaching developmental milestones, such as motor skills (crawling, walking) or language development (speech).

5-Intellectual Disability: Intellectual disability or learning difficulties can occur in some individuals with BRRS. The severity can range from mild to moderate.

6-Muscle Hypotonia: Reduced muscle tone or muscle weakness, known as hypotonia, may be observed in individuals with BRRS. This can affect motor skills and coordination.

7-Vascular Anomalies: BRRS is associated with certain vascular abnormalities, such as abnormal blood vessels or an increased risk of blood clots. These vascular anomalies can vary and may lead to specific health concerns.

8-Gastrointestinal Polyps: Polyps, growths on the lining of the gastrointestinal tract, can occur in individuals with BRRS. These polyps most commonly affect the colon.

It’s important to note that not all individuals with BRRS will experience all of these symptoms, and the severity of each symptom can vary. Additionally, BRRS shares overlapping features with other conditions associated with PTEN gene mutations, such as Cowden syndrome and PTEN hamartoma tumor syndrome (PHTS).

If you or someone you know exhibits any of these symptoms or features associated with BRRS, it is important to consult with a medical geneticist or other healthcare professionals experienced in genetic disorders for proper evaluation, diagnosis, and management.

What causes BRRS?

Bannayan-Riley-Ruvalcaba Syndrome (BRRS) is primarily caused by mutations in the PTEN gene. The PTEN gene provides instructions for producing a protein called phosphatase and tensin homolog, which plays a crucial role in regulating cell growth and division. Mutations in the PTEN gene can disrupt the normal function of this protein, leading to the development of BRRS and other related conditions.

Most cases of BRRS are sporadic, meaning the genetic mutation occurs for the first time in an affected individual and is not inherited from their parents. These sporadic cases are often caused by new (de novo) mutations that arise during early embryonic development.

However, BRRS can also be inherited in an autosomal dominant manner. This means that if an individual has BRRS due to a PTEN gene mutation, there is a 50% chance that each of their children will inherit the mutation and develop the syndrome.

It’s important to note that the PTEN gene mutations associated with BRRS can also cause other related disorders, such as Cowden syndrome and PTEN hamartoma tumor syndrome (PHTS). These conditions share overlapping features with BRRS and can present challenges in accurately diagnosing and distinguishing between them.

Genetic testing, typically through DNA sequencing of the PTEN gene, can help confirm a diagnosis of BRRS and identify specific mutations. Genetic counseling is often recommended for individuals with BRRS and their families to discuss the inheritance pattern, risk of passing on the mutation, and appropriate management strategies.

It’s worth noting that while PTEN gene mutations are the primary known cause of BRRS, there may be other rare genetic or molecular mechanisms that can result in a similar clinical presentation. Research in this field continues to expand our understanding of the underlying causes of BRRS.

How is BRRS inherited?

Bannayan-Riley-Ruvalcaba Syndrome (BRRS) is primarily inherited in an autosomal dominant pattern. Autosomal dominant inheritance means that an affected individual has a 50% chance of passing the condition on to each of their children. Here are some key points about the inheritance of BRRS:

1-Autosomal Dominant Inheritance: BRRS follows an autosomal dominant inheritance pattern. This means that if a person carries a mutation in the PTEN gene that causes BRRS, they have a 50% chance of passing the mutation to each of their children.

2-Sporadic Cases: In many instances, BRRS occurs as a sporadic case. Sporadic cases arise from new (de novo) mutations that occur during early embryonic development and are not inherited from the parents. These de novo mutations can be present in an affected individual but are not present in their parents’ germline (sperm or egg cells).

3-Inherited Cases: BRRS can also be inherited from an affected parent. In these cases, one of the parents carries the mutated PTEN gene and passes it on to their child. In each pregnancy, there is a 50% chance that the child will inherit the mutation and develop BRRS.

4-Variable Expression: While BRRS follows an autosomal dominant inheritance pattern, it’s important to note that the clinical features and severity can vary among affected individuals, even within the same family. Some individuals may exhibit milder symptoms or may be asymptomatic carriers of the PTEN gene mutation.

5-Germline Mosaicism: In rare cases, a parent may not show any clinical signs of BRRS but still carry the PTEN gene mutation in their germline (sperm or egg cells). This is known as germline mosaicism. In these cases, the parent can pass the mutation on to their child, even though they themselves do not manifest the syndrome.

Genetic testing, typically through DNA sequencing of the PTEN gene, can help identify the presence of a PTEN gene mutation in individuals with BRRS or those at risk of inheriting the condition. Genetic counseling is recommended for affected individuals and their families to understand the inheritance pattern, potential risks, and appropriate management options.

It’s important to consult with healthcare professionals experienced in genetic disorders, such as medical geneticists or genetic counselors, for accurate diagnosis, genetic testing, and personalized guidance regarding inheritance patterns and family planning options.

How is BRRS diagnosed?

Bannayan-Riley-Ruvalcaba Syndrome (BRRS) is diagnosed through a combination of clinical evaluation, assessment of characteristic features, and genetic testing. The diagnosis is typically made by healthcare professionals with expertise in genetic disorders, such as medical geneticists. Here are the key steps involved in diagnosing BRRS:

1-Clinical Evaluation: A thorough clinical evaluation is conducted, considering the individual’s medical history, family history, and a physical examination. The presence of characteristic features associated with BRRS, such as macrocephaly (enlarged head size), lipomas, and pigmented macules, is assessed.

2-Genetic Testing: Genetic testing plays a crucial role in diagnosing BRRS. It involves DNA sequencing of the PTEN gene to identify specific mutations or variants that are associated with BRRS. Blood or saliva samples are typically used for genetic testing. In some cases, genetic testing may include analysis of the PTEN gene in tumor tissue if there are associated tumors.

3-Differential Diagnosis: BRRS shares overlapping features with other conditions associated with PTEN gene mutations, such as Cowden syndrome and PTEN hamartoma tumor syndrome (PHTS). Distinguishing between these conditions may require careful evaluation of clinical features, genetic testing results, and consideration of specific diagnostic criteria for each disorder.

4-Medical Imaging and Additional Testing: Depending on the individual’s symptoms and clinical presentation, additional tests and medical imaging studies may be conducted to assess specific organ systems or associated conditions. For example, imaging of the brain, gastrointestinal tract, or other affected areas may be performed to identify any abnormalities.

5-Genetic Counseling: Genetic counseling is an important component of the diagnostic process. It involves discussing the genetic cause of BRRS, the inheritance pattern, potential risks to family members, and available management and surveillance strategies. Genetic counselors provide support, education, and guidance to individuals and families affected by BRRS.

It’s crucial to consult with healthcare professionals experienced in genetic disorders for an accurate diagnosis of BRRS. They can guide the diagnostic process, interpret genetic testing results, and provide appropriate recommendations for management and surveillance based on the individual’s specific needs.

How is BRRS treated?

Bannayan-Riley-Ruvalcaba Syndrome (BRRS) does not have a specific cure, as it is a genetic disorder. However, the management of BRRS focuses on addressing the individual symptoms, minimizing complications, and providing appropriate medical surveillance. Treatment options and recommendations may vary depending on the specific features and needs of each affected individual. Here are some aspects of the management and treatment of BRRS:

1-Regular Medical Surveillance: Regular medical follow-up is essential for individuals with BRRS to monitor their overall health and identify any potential complications or associated conditions. This may involve visits to various specialists, such as medical geneticists, dermatologists, neurologists, gastroenterologists, and other healthcare professionals, as needed.

2-Surgical Management: In some cases, surgical intervention may be necessary to address specific symptoms or complications associated with BRRS. For example, lipomas (noncancerous fatty tumors) that cause discomfort or functional impairment may be surgically removed. Gastrointestinal polyps, if present, may require surveillance and, if necessary, removal to minimize the risk of complications.

3-Developmental Support and Early Intervention: Children with BRRS who experience developmental delays or intellectual disabilities may benefit from early intervention services, such as physical therapy, occupational therapy, and speech therapy. These interventions can help promote their physical and cognitive development, improve motor skills, and enhance communication abilities.

4-Genetic Counseling and Family Support: Genetic counseling is an important aspect of BRRS management. Genetic counselors can provide information about the inheritance pattern, the risk of passing on the PTEN gene mutation to offspring, and reproductive options. They can also offer emotional support and connect affected individuals and their families with support groups or resources for additional support and guidance.

5-Screening for Associated Conditions: BRRS is associated with an increased risk of certain conditions, such as certain types of cancer and vascular abnormalities. Therefore, regular screening and surveillance for these conditions may be recommended. The specific screening protocols and timing may vary depending on individual factors and family history.

It’s important for individuals with BRRS to have a comprehensive and personalized care plan that addresses their specific needs. Regular communication and coordination among healthcare professionals involved in their care, as well as open dialogue with the affected individual and their family, can help optimize management and support their overall well-being.

It’s worth noting that the management of BRRS is constantly evolving, and new treatments or approaches may emerge as our understanding of the condition progresses. Therefore, it is important to consult with healthcare professionals experienced in genetic disorders for up-to-date information and recommendations.

Can you prevent BRRS?

Bannayan-Riley-Ruvalcaba Syndrome (BRRS) is a genetic disorder caused by mutations in the PTEN gene. Currently, there are no known methods to prevent the development of BRRS in individuals who carry the PTEN gene mutation. The condition can occur sporadically through de novo mutations or be inherited from an affected parent.

However, if there is a known family history of BRRS or a PTEN gene mutation, genetic counseling can be beneficial. Genetic counselors can provide information about the inheritance pattern, the likelihood of passing on the mutation, and available reproductive options. Preimplantation genetic diagnosis (PGD) may be an option for families who wish to have children without the PTEN gene mutation, but this approach requires in vitro fertilization (IVF) and is subject to various considerations and limitations.

Additionally, individuals who have been diagnosed with BRRS or carry a PTEN gene mutation can take certain steps to manage the condition and reduce the risk of associated complications. These measures may include:

1-Regular Medical Surveillance: Regular check-ups and medical screenings can help monitor overall health and identify any potential complications or associated conditions. Following the recommended surveillance protocols can aid in early detection and timely management of any emerging issues.

2-Healthy Lifestyle Choices: Adopting a healthy lifestyle, including a balanced diet, regular exercise, and avoiding tobacco and excessive alcohol consumption, can promote general well-being and potentially reduce the risk of certain complications associated with BRRS.

3-Awareness and Early Intervention: Being aware of the signs and symptoms associated with BRRS and seeking medical attention promptly can lead to early intervention and management of any emerging issues. This may involve addressing developmental delays, managing lipomas, or treating other specific symptoms or conditions.

It’s important to consult with healthcare professionals experienced in genetic disorders, such as medical geneticists or genetic counselors, to discuss specific preventive measures and management strategies based on individual circumstances and family history.

Please note that the information provided here is for general knowledge, and the best course of action can vary depending on individual factors. Consulting with healthcare professionals familiar with the individual’s medical history and genetic profile is crucial for personalized guidance and recommendations.

What can I expect if I have BRRS?

If you have been diagnosed with Bannayan-Riley-Ruvalcaba Syndrome (BRRS), it’s important to understand that the condition can vary in its presentation and severity among affected individuals. The specific symptoms and features of BRRS can differ from person to person. However, here are some general aspects you can expect if you have BRRS:

1-Physical Features: BRRS is often characterized by certain physical features. These may include macrocephaly (enlarged head size), lipomas (noncancerous fatty tumors), and pigmented macules (dark spots or freckles) on the penis, vulva, or lips. The severity and distribution of these features can vary.

2-Developmental Delays: Some individuals with BRRS may experience developmental delays, particularly in areas such as motor skills (crawling, walking) or language development (speech). The delays can range from mild to moderate and may require early intervention and support.

3-Intellectual Disability: Intellectual disability or learning difficulties can occur in individuals with BRRS. The severity can vary, ranging from mild to moderate. Supportive interventions and accommodations may be beneficial to address educational and cognitive needs.

4-Increased Risk of Tumors: BRRS is associated with an increased risk of certain types of tumors, including benign and malignant tumors. Regular surveillance and screenings may be recommended to monitor for the development of these tumors and enable early detection and intervention if necessary.

5-Vascular Anomalies: BRRS can be associated with specific vascular abnormalities, which can vary among individuals. These anomalies may include abnormal blood vessels or an increased risk of blood clots. Depending on the specific vascular issues, management and surveillance strategies may be recommended.

6-Gastrointestinal Polyps: Some individuals with BRRS may develop polyps, which are growths on the lining of the gastrointestinal tract, most commonly in the colon. Regular monitoring and appropriate management of these polyps may be necessary to prevent complications.

7-Genetic Implications: BRRS is caused by mutations in the PTEN gene, which can have implications for family members. If you have BRRS, there is a 50% chance of passing on the PTEN gene mutation to each of your children. Genetic counseling can provide guidance regarding family planning options, reproductive choices, and genetic testing for family members.

It’s important to note that the specific manifestations of BRRS can vary widely. The management and prognosis will depend on the individual’s specific symptoms, associated conditions, and overall health. Regular medical follow-up, genetic counseling, and appropriate screenings are essential for monitoring and managing the condition effectively.

Working closely with healthcare professionals experienced in genetic disorders, such as medical geneticists or genetic counselors, can provide personalized guidance, support, and access to resources specific to your situation.

When should I see my healthcare provider?

It is important to regularly see your healthcare provider if you have been diagnosed with Bannayan-Riley-Ruvalcaba Syndrome (BRRS) or if you suspect that you may have the condition. Regular medical follow-up and monitoring can help address any emerging issues, manage symptoms, and reduce the risk of complications associated with BRRS. Here are some specific situations in which you should consider scheduling an appointment with your healthcare provider:

1-Diagnosis and Genetic Counseling: If you have not yet been diagnosed with BRRS but suspect that you may have the condition due to the presence of characteristic features or a family history of BRRS, it is advisable to consult with a healthcare provider experienced in genetic disorders. They can assess your symptoms, conduct necessary evaluations, and refer you to genetic testing and counseling services for a definitive diagnosis and appropriate guidance.

2-Regular Check-ups: Routine visits to your healthcare provider, as recommended by your healthcare team, are essential for ongoing management and monitoring of your condition. These check-ups may involve assessing your physical features, monitoring developmental milestones, evaluating associated conditions, and discussing any concerns or symptoms you may have.

3-Surveillance and Screenings: Depending on your specific situation and associated risks, your healthcare provider may recommend regular screenings and surveillance for certain conditions. This can include imaging studies, laboratory tests, or other evaluations to monitor for the development of tumors, vascular anomalies, or gastrointestinal polyps. Adhering to the recommended surveillance schedule is crucial for early detection and intervention, if necessary.

4-Developmental Support: If you or your child with BRRS experience developmental delays, intellectual disability, or learning difficulties, it is important to consult with healthcare professionals who specialize in developmental pediatrics or early intervention services. They can provide appropriate assessments, therapeutic interventions, and educational support to help optimize development and address specific needs.

5-Concerns or New Symptoms: If you experience any new symptoms or have concerns related to BRRS, such as changes in physical features, unexpected growths or lumps, neurological symptoms, or any other health issues, it is advisable to contact your healthcare provider. They can evaluate the symptoms, provide guidance, and determine if further investigation or intervention is necessary.

Remember, regular communication and coordination with your healthcare provider, genetic counselor, and specialists involved in your care are crucial for the management of BRRS. They can provide personalized guidance, address specific concerns, and ensure that you receive appropriate care based on your individual needs and situation.